These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26142543)

  • 1. Mesenchymal stromal cells and rheumatic disorders.
    Tyndall A
    Immunol Lett; 2015 Dec; 168(2):201-7. PubMed ID: 26142543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell transplantation and mesenchymal cells to treat autoimmune diseases.
    Tyndall A; van Laar JM
    Presse Med; 2016 Jun; 45(6 Pt 2):e159-69. PubMed ID: 27256975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
    El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
    Front Immunol; 2021; 12():643170. PubMed ID: 33732263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of osteoarthritis with mesenchymal stem cells.
    Wang W; Cao W
    Sci China Life Sci; 2014 Jun; 57(6):586-95. PubMed ID: 24849513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue Engineering in Osteoarthritis: Current Status and Prospect of Mesenchymal Stem Cell Therapy.
    Im GI
    BioDrugs; 2018 Jun; 32(3):183-192. PubMed ID: 29704190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCL2 expression.
    Che N; Li X; Zhang L; Liu R; Chen H; Gao X; Shi S; Chen W; Sun L
    J Immunol; 2014 Nov; 193(10):5306-14. PubMed ID: 25339674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-Articular Transplantation of Allogeneic BMMSCs Rehabilitates Cartilage Injury of Antigen-Induced Arthritis.
    Liu H; Ding J; Wang C; Wang J; Wang Y; Yang M; Jia Y; Zhang Y; Chang F; Li R; Chen X
    Tissue Eng Part A; 2015 Nov; 21(21-22):2733-43. PubMed ID: 26414238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?].
    Larghero J; Vija L; Lecourt S; Michel L; Verrecchia F; Farge D
    Rev Med Interne; 2009 Mar; 30(3):287-99. PubMed ID: 18930338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stem cell treatment of autoimmune disease].
    Daikeler T; Tyndall A
    Dtsch Med Wochenschr; 2011 Aug; 136(33):1684-6. PubMed ID: 21833894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Developments in Clinical Applications of Mesenchymal Stem Cells in the Treatment of Rheumatoid Arthritis and Osteoarthritis.
    Hwang JJ; Rim YA; Nam Y; Ju JH
    Front Immunol; 2021; 12():631291. PubMed ID: 33763076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on mesenchymal stem cell-based therapy in lupus and scleroderma.
    Cras A; Farge D; Carmoi T; Lataillade JJ; Wang DD; Sun L
    Arthritis Res Ther; 2015 Nov; 17():301. PubMed ID: 26525582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives.
    Pers YM; Ruiz M; Noël D; Jorgensen C
    Osteoarthritis Cartilage; 2015 Nov; 23(11):2027-35. PubMed ID: 26521749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis.
    Frisbie DD; Kisiday JD; Kawcak CE; Werpy NM; McIlwraith CW
    J Orthop Res; 2009 Dec; 27(12):1675-80. PubMed ID: 19544397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stromal cells and the innate immune response.
    Le Blanc K; Davies LC
    Immunol Lett; 2015 Dec; 168(2):140-6. PubMed ID: 25982165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
    Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
    Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis].
    Liu S; Guo YL; Yang JY; Wang W; Xu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1014-1021. PubMed ID: 30562774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder.
    Fathollahi A; Gabalou NB; Aslani S
    Lupus; 2018 Jun; 27(7):1053-1064. PubMed ID: 29631514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potential of bone regenerative therapy with mesenchymal stem cells in rheumatoid arthritis].
    Yamaoka K
    Clin Calcium; 2016 May; 26(5):758-62. PubMed ID: 27117623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cell Therapy for Autoimmune Disease: Risks and Rewards.
    Munir H; McGettrick HM
    Stem Cells Dev; 2015 Sep; 24(18):2091-100. PubMed ID: 26068030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.